Streetbeat News

Corporate Responsibility

SGBX

Safe & Green Holdings Corp. (NASDAQ:SGBX) has announced a collaboration and sales of modular units to Britten Inc., a creative production house. The units have received AC 462 Evaluation Service Report designation, facilitating jurisdictional approvals and code compliance. This partnership aims to promote sustainable building practices and enhance the efficiency of building solutions. No financial terms were disclosed.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:33 pm

DOW

Dow (NYSE:DOW) has agreed to sell its flexible packaging laminating adhesives business to Arkema for $150 million, approximately 10 times its forecasted 2024 EBITDA. This sale includes five manufacturing sites across Italy, the United States, and Mexico. The transaction, expected to close by the end of 2024, aligns with Dow's strategy to focus on core, high-value businesses and supports its Decarbonize & Grow and Transform the Waste strategies. Dow will retain its water-based and acrylic adhesives businesses, aligning with its market growth strategies.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:23 pm

XOS

Xos, Inc. has received approval from the California Air Resources Board for its 2024 Xos SV Battery Electric Stepvan to be listed on the Clean Truck and Bus Voucher Incentive Program (HVIP) Catalog. This listing enables Xos to offer their electric stepvan at a reduced cost to customers, with incentives starting at $85,000.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:20 pm

QDEL

QuidelOrtho announced the appointment of Brian Blaser as President and CEO, effective May 6, 2024. Blaser will also join the Board on May 15, 2024, when it expands to eleven members. The company plans to report its Q1 2024 financial results on May 8, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:19 pm

CRL

Charles River Laboratories International, Inc. (NYSE:CRL) has launched a new portfolio of reference materials for AAV and LVV, aimed at streamlining Cell and Gene Therapy (CGT) research and development towards GMP quality. This includes six AAV serotypes and five LVV products, enhancing their CDMO offerings and supporting the transition from discovery to commercial stages in CGT.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:14 pm

TSLA

Mark Hawtin of GAM Investments expressed concerns about Tesla Inc.'s fundamentals and demand, despite its stock surge. He cited increasing competition in the EV market and potential issues from Tesla's aggressive price cuts. Tesla's Q1 earnings showed a 9% revenue decrease year-over-year, missing estimates, and the company announced layoffs as part of cost-cutting measures. Skepticism also surrounds Tesla's robo-taxis viability and its full self-driving software rollout in China.

Portfolio Pulse from Benzinga Neuro

May 02, 2024 | 12:12 pm

NDRA

ENDRA Life Sciences has announced the issuance of three new patents in Europe and two in China, marking a significant advancement in its intellectual property portfolio.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:12 pm

CDTG

CDT Environmental Technology Investment Holdings Limited (NASDAQ:CDTG) has been granted three new utility model patents by the China National Intellectual Property Administration (CNIPA). These patents are for innovations in waste treatment, including a sludge drying device, a wastewater treatment device for nitrogen and phosphorus removal, and a highly efficient waste anaerobic fermentation device. These developments are aimed at enhancing efficiency, reducing energy consumption, and minimizing environmental pollution in waste management.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:11 pm

LFMD

LifeMD, Inc. (NASDAQ:LFMD) partners with Withings Health Solutions to enhance GLP-1 weight-loss patient care by providing advanced in-home health monitoring devices. This strategic partnership aims to improve patient outcomes through real-time data for clinicians, supporting weight management with online consultations, prescriptions, and laboratory testing. The use of Withings' Body Pro 2 scale and BPM Connect Pro blood pressure monitor sets a new standard in virtual care, enabling better clinical decisions and long-term health improvements.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:09 pm

NDRA

ENDRA Life Sciences Inc. (NASDAQ:NDRA) has announced the issuance of five new international patents, enhancing its intellectual property portfolio to 80 issued patents globally. These patents, including three in Europe and two in China, protect the company's Thermo Acoustic Enhanced UltraSound (TAEUS) technology, offering potential for growth through licensing opportunities and applications beyond its core focus.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:08 pm